期刊文献+

化疗灌注结合益气活血汤在中晚期膀胱癌治疗中的对照研究 被引量:2

Control Study of Irrigation Chemotherapy Combined with Qi-invigorating and Blood-activating Decoction in Treating Bladder Cancer at Moderate and Advanced Stages
暂未订购
导出
摘要 目的:探讨化疗灌注结合益气活血汤在中晚期膀胱癌治疗中的效果。方法:将180例中晚期膀胱癌患者随机分为治疗组与对照组各90例,所有患者均给予双侧髂内动脉化疗灌注治疗,在此基础上治疗组加用益气活血汤口服治疗。结果:所有患者治疗后出院,治疗组的心理、独立性、社会关系和环境维度评分明显高于对照组(P<0.05)。治疗组的1年生存率为98.9%,对照组为91.1%,组间对比差异有统计学意义(P<0.05)。2组治疗前CD4+、CD8+、NK细胞值对比差异无统计学意义,治疗后治疗组的CD4+与NK细胞值明显上升(P<0.05),CD8+值明显下降,组间对比有统计学意义(P<0.05)。结论:化疗灌注结合益气活血汤应用于中晚期膀胱癌的治疗能促进患者康复,提高患者生存率,这可能与有效改善免疫状态有关。 Objective: To explore the effects of irrigation chemotherapy combined with Qi-invigorating and blood-activating decoction in treating bladder cancer at moderate and advanced stages. Methods: All 180 patients were randomly separated into the treatment group and the control group, 90 cases each group. All the patients were administered with internal iliac artery irrigation chemotherapy bilaterally, the treatment group took Qi-invigorating and blood-activating decoction. Results:When all the patients were discharged, the treatment group was significantly higher than the control group in the psychology, independence, social relationship and the environment (P〈0.05). One-year survival rate of the treatment group was 98.9%, higher than 91.1% of the control group, the difference demonstrated statistical meaning (P〈0.05). The difference had no statistical meaning before treating in CD4+, CD8+and NK cell values, after treating, CD4+and NK cell values of the treatment group were raised obviously (P〈0.05), CD8+was decreased remarkably, the comparison between both groups presented statistical meaning (P〈0.05). Con-clusion:Irrigation chemotherapy combined with Qi-invigorating and blood-activating decoction applied to bladder cancer at moderate and advanced stages could promote the recovery of the patients, lift survival rate of the patients, which might be related to effective improvement of immunity.
作者 裴建强
出处 《西部中医药》 2014年第6期4-6,共3页 Western Journal of Traditional Chinese Medicine
关键词 中晚期膀胱癌 化疗灌注 益气活血汤 生存质量 免疫 bladder cancer at moderate and advanced stages irrigation chemotherapy Qi-invigorating and blood-activating decoction life quality immunity
  • 相关文献

参考文献15

二级参考文献44

  • 1罗健,孙燕.癌症患者的生活质量研究(一)[J].中国肿瘤,1995,4(10):15-19. 被引量:34
  • 2谢立平,毛祺琦.膀胱癌发病及影响预后的危险因素[J].临床外科杂志,2009,17(11). 被引量:7
  • 3蔡丹,王志华,胡志全,张旭,周四维,叶章群.膀胱癌患者外周血树突状细胞的体外培养扩增和鉴定[J].中华泌尿外科杂志,2006,27(7):472-474. 被引量:2
  • 4李家邦,祝赛君.生血宝治疗放化疗后白细胞减少症106例疗效观察[J].中国中西医结合杂志,1996,16(12):753-753. 被引量:4
  • 5MESSING E M.Urothelial tumors of the urinary tract[M] //Campbell's urology.8th ad.WALSH P C,RETIK A B,VAUGHAN E D J R,WEIN A J,eds.Philadelphia(PA):W.B.Saunders,2002:2732-2784.
  • 6RO J Y,STAERKEL G A,AYALA A G.Cytologic and histologic features of superficial bladder cancer[J].Urol Clin North Am,1992,19(3):435-553.
  • 7BRAUSI M,CLLETE L,KURTH K.Variability in the recurrencen rate at first follow-up cystescopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder:a combined analysis of seven EORTC studies[J].Eur Urol,2002,41:523-531.
  • 8KURODA M,NIJIMAT,KOTAKET,et al.Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer.The 6th Trial of the Japanese Urological Cancer Research Group(JUCRG):a randomized trial of intravesical epirubicin at dose of 20mg/40ml,30mg/40ml,40 mg/40 mL[J].Eur Urol,2004,45:600-605.
  • 9Grimm MO, Steinhoff C, Simon X, et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol, 2003, 170: 433-437.
  • 10Sobin LH, Wittekind Ch. TNM classification of malignant tumours. 6th ed. Wiley-Liss: New York, 2002: 199-202.

共引文献55

同被引文献16

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部